It’s no longer sufficient for a pharma to develop better products or even build simple apps. The industry increasingly needs to create sophisticated predictive algorithms to maximize the ability of its products, write Tom Agan and Fred Geyer.
Tom Agan and Fred Geyer
Advertisement
Tom Agan and Fred Geyer are Partners at Prophet, a global consultancy.
Articles by Tom Agan and Fred Geyer
Advertisement
Latest Updated Articles
The New Age of BioDigital PharmaPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
3
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
4
Could DTC Programs Help Simplify the Drug-Pricing System?
5
